Help! Please Register

  The Fungi

  Introduction
  Descriptions
  Synonyms
  Image Bank
  Lecture Bank
  Video Bank


  Mycoses

  Introduction
  Human
  Veterinary
  Environmental
   Industrial
  Agricultural
  MSG


  Drugs

  Introduction
  Medical
  Veterinary
  Environmental
   Industrial
  Agricultural


  Laboratory

  Introduction
  Susceptibility
  MIC Database
  Procedures
  Histopathology


  Education &
  Tools

  Introduction
  Abbreviations
  Links
  CME
  Conference
   Highlights
  Bibliography
  Glossary
  Good Books
  Events Calendar


  About Us

  Introduction
  Our Mission
  Editorial Board
  Editorial Staff
  Supporters
  Contributors
  Legal Stuff
  Privacy Policy
  Kudos


  The Fungi

  Introduction
  Descriptions
  Synonyms
  Image Bank
  Lecture Bank
  Video Bank



This page updated:
1/27/2007 9:23:00 AM


DoctorFungus - All Rights Reserved © 2007 Copyright
& Privacy Policy


Site built and designed for doctorfungus by Webillustrated



You are here: The Fungi > Descriptions >


Candida lusitaniae
van Uden & do Carmo-Sousa (1959)

 


Teleomorph:

Clavispora lusitaniae Rodrigues de Miranda (1979)

Macroscopic morphology

Colonies on Sabouraud dextrose agar at 25°C are white to cream, glistening, and smooth but may be rugose. Colonies may be fringed with pseudohyphae. This isolate grows both at 42°C and on media containing cycloheximide.

Microscopic morphology

On cornmeal following 72 hours incubation at 25°C, abundant branched pseudohyphae may be present. Some strains have rudimentary to no pseudohyphae.

Special notes

Candida lusitaniae is known for amphotericin B resistance. The first report of fatal infection occurred in a neutropenic patient where the initial isolate was susceptible to amphotericin B but subsequent isolates had developed amphotericin B resistance [1712]. It is well-documented that this species is able to develop resistance, but some strains display resistance prior to amphotericin B therapy [1524]. Although amphotericin B resistance is a concern, reports exist where amphotericin B has been used to successfully treat fungemia in severely immunocompromised patients [259].

FTL* in vitro susceptibility data

AMB CAS 5FC FLU ITRA VORI KETO
0.06 µg/ml=2 <0.03 µg/ml=6 <0.125 µg/ml=41 <0.125 µg/ml=7 <0.015 µg/ml=13 <0.015 µg/ml=27 <0.03 µg/ml=8
0.125 µg/ml=35 0.06 µg/ml=33 0.25 µg/ml=1 0.25 µg/ml=24 0.03 µg/ml=23 0.03 µg/ml=16 0.06 µg/ml=6
0.25 µg/ml=72 0.125 µg/ml=50 4.0 µg/ml=1 0.5 µg/ml=57 0.06 µg/ml=24 0.06 µg/ml=5 0.125 µg/ml=4
0.5 µg/ml=14 0.25 µg/ml=18 64 µg/ml=1 1.0 µg/ml=42 0.125 µg/ml=12 0.125 µg/ml=5 0.25 µg/ml=1
1.0 µg/ml=5 0.5 µg/ml=3 >64 µg/ml=2 2.0 µg/ml=9 0.25 µg/ml=8 0.25 µg/ml=3  
2.0 µg/ml=1 1.0 µg/ml=4   16 µg/ml=3 0.5 µg/ml=1 0.5 µg/ml=3  
  2.0 µg/ml=1   32 µg/ml=4 4.0 µg/ml=1 2.0 µg/ml=1  
      64 µg/ml=6   4.0 µg/ml=1  
      >64 µg/ml=1   8.0 µg/ml=1  


Drug/N AMB/129 CAS/115 5FC/46 FLU/153 ITRA/82 VORI/62 KETO/19
MIC Range 0.06-2.0 <0.03-2.0 <0.125->64 <0.125->64 <0.015-4.0 <0.015-8 <0.03-0.25
MIC50 0.25 0.125 <0.125 0.5 0.06 0.03 0.06
MIC90 0.5 0.25 0.25 2.0 0.25 0.25 0.125
* Fungus Testing Laboratory unpublished data (NCCLS M27-A2)


Search

PubMed

Nucleotides

GenBank




References

259. Blinkhorn, R. J., D. Adelstein, and P. J. Spagnuolo. 1989. Emergence of a new opportunistic pathogen, Candida lusitaniae. J. Clin. Microbiol. 27:236-240.

1524. Merz, W. G. 1984. Candida lusitaniae: frequency of recovery, colonization, infection, and amphotericin B resistance. J. Clin. Microbiol. 20:1194-1195.

1712. Pappagianis, D., M. S. Collins, R. Hector, and J. Remington. 1979. Development of reistance to amphotericin B in Candida lusitaniae infecting a human. Antimicrob. Agents Chemother. 16:123-126.



  Home | Image Bank | Lecture Bank | Knowledgebase | Site Map | Contact Us |
The Fungi | Mycoses | Drugs |
Laboratory | Education & Tools | About Us

  bttm_banner_indv2_02[1].gif